US2014303099A1PendingUtilityA1

Compositions and Methods for Improving Cardiovascular Health

48
Assignee: ENERGY LIGHT LLCPriority: Jan 31, 2008Filed: Apr 14, 2014Published: Oct 9, 2014
Est. expiryJan 31, 2028(~1.6 yrs left)· nominal 20-yr term from priority
A61P 9/10A61P 9/00A61K 31/4172A61K 31/197A61K 45/06A61K 31/201A61K 31/575A61P 21/00A61K 31/198
48
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Compositions and methods for improving cardiovascular health, especially in the elderly, by delivering a selection of essential amino acids selected from the group of histidine, isoleucine, leucine, valine, lysine, methionine, phenylalanine, threonine, and arginine, which may be supplemented with a low glycemic carbohydrate and/or a medium chain fatty acid.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A composition of matter for improving cardiovascular health comprising an amino acid blend, the blend comprising: about 0.36 g histidine; about 0.94 g isoleucine; about 3.95 g leucine; about 1.88 g lysine; about 0.39 g methionine; about 0.51 g phenylalanine; about 1.05 g threonine; about 0.82 g valine; and 1.10 g arginine. 
     
     
         2 . The composition of  claim 1  further comprising a low glycemic carbohydrate. 
     
     
         3 . The composition of  claim 1  further comprising a medium chain fatty acid. 
     
     
         4 . The composition of  claim 2 , wherein said low glycemic carbohydrate has a combined mass of about 0.01 to about 15 g. 
     
     
         5 . The composition of  claim 3 , wherein said medium chain fatty acid has a combined mass of about 0.01 to about 15 g. 
     
     
         6 . The composition of  claim 1  further comprising supplemental minerals. 
     
     
         7 . The composition of  claim 1  further comprising vitamins. 
     
     
         8 . The composition of  claim 1  further comprising an excipient. 
     
     
         9 . A composition of matter for the reduction of liver fat, the composition consisting essentially of: about 0.36 g histidine; about 0.94 g isoleucine; about 3.95 g leucine; about 1.88 g lysine; about 0.39 g methionine; about 0.51 g phenylalanine; about 1.05 g threonine; about 0.82 g valine; and about 1.10 g arginine. 
     
     
         10 . The composition of  claim 9  further consisting essentially of a low glycemic carbohydrate. 
     
     
         11 . The composition of  claim 9  further consisting essentially of a medium chain fatty acid. 
     
     
         12 . The composition of  claim 10 , wherein said low glycemic carbohydrate has a combined mass of about 0.01 to about 15 g. 
     
     
         13 . The composition of  claim 11 , wherein said medium chain fatty acid has a combined mass of about 0.01 to about 15 g. 
     
     
         14 . The composition of  claim 10  further consisting essentially of supplemental minerals and or vitamins. 
     
     
         15 . A method of improving cardiovascular health comprising: having a patient; and delivering to said patient a composition of matter for improving cardiovascular health comprising amino acids selected from the group of histidine, isoleucine, leucine, valine, lysine, methionine, phenylalanine, threonine, and arginine. 
     
     
         16 . The method of  claim 15  wherein said composition further comprises a low glycemic carbohydrate. 
     
     
         17 . The method of  claim 15  wherein said composition further comprises a medium chain fatty acid. 
     
     
         18 . The method of  claim 15  wherein said amino acids have a combined mass of about 11 grams; and wherein said amino acids further comprise about 0.36 g histidine, about 0.94 g isoleucine, about 3.95 g leucine, about 1.88 g lysine, about 0.39 g methionine, about 0.51 g phenylalanine, about 1.05 g threonine, about 0.82 g valine, and about 1.10 g arginine. 
     
     
         19 . The method of  claim 15  wherein said delivering further comprises delivering said composition orally to said patient twice daily. 
     
     
         20 . The method of  claim 15  wherein said patient is over sixty-five years of age.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.